As of 2025-09-18, the Relative Valuation of Catalyst Pharmaceuticals Inc (CPRX) is 21.88 USD. This relative valuation is based on P/E multiples. With the latest stock price at 20.02 USD, the upside of Catalyst Pharmaceuticals Inc based on Relative Valuation is 9.3%.
The range of the Relative Valuation is 19.81 - 33.30 USD.
| Range | Selected | |
| Trailing P/E multiples | 12.6x - 16.2x | 13.9x |
| Forward P/E multiples | 13.9x - 23.4x | 14.1x |
| Fair Price | 19.81 - 33.30 | 21.88 |
| Upside | -1.1% - 66.3% | 9.3% |
| Date | P/E |
| 2025-09-17 | 11.74 |
| 2025-09-16 | 11.77 |
| 2025-09-15 | 11.59 |
| 2025-09-12 | 11.71 |
| 2025-09-11 | 11.88 |
| 2025-09-10 | 11.58 |
| 2025-09-09 | 11.73 |
| 2025-09-08 | 11.78 |
| 2025-09-05 | 11.90 |
| 2025-09-04 | 11.61 |
| 2025-09-03 | 11.61 |
| 2025-09-02 | 12.05 |
| 2025-08-29 | 12.08 |
| 2025-08-28 | 11.95 |
| 2025-08-27 | 11.84 |
| 2025-08-26 | 11.70 |
| 2025-08-25 | 12.09 |
| 2025-08-22 | 12.36 |
| 2025-08-21 | 12.06 |
| 2025-08-20 | 11.93 |
| 2025-08-19 | 11.88 |
| 2025-08-18 | 11.87 |
| 2025-08-15 | 11.87 |
| 2025-08-14 | 11.77 |
| 2025-08-13 | 11.84 |
| 2025-08-12 | 11.93 |
| 2025-08-11 | 11.54 |
| 2025-08-08 | 11.65 |
| 2025-08-07 | 11.52 |
| 2025-08-06 | 12.78 |
| 2025-08-05 | 13.03 |
| 2025-08-04 | 12.75 |
| 2025-08-01 | 12.39 |
| 2025-07-31 | 12.51 |
| 2025-07-30 | 12.48 |
| 2025-07-29 | 12.33 |
| 2025-07-28 | 12.20 |
| 2025-07-25 | 12.30 |
| 2025-07-24 | 12.33 |
| 2025-07-23 | 12.65 |
| 2025-07-22 | 12.26 |
| 2025-07-21 | 12.32 |
| 2025-07-18 | 12.33 |
| 2025-07-17 | 12.58 |
| 2025-07-16 | 12.42 |
| 2025-07-15 | 12.29 |
| 2025-07-14 | 12.68 |
| 2025-07-11 | 12.79 |
| 2025-07-10 | 12.82 |
| 2025-07-09 | 12.68 |